MATRIXLABS

Matrix Laboratories Limited has informed the Exchange vide its letter dated August 07, 2009, regarding a press release dated August 06, 2009, titled "President Clinton and Mylan Chairman and CEO Robert J. Coury announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/MATRIX_PR_070809.zip target=NEW> For more details clic

Matrix Laboratories Limited has informed the Exchange regarding a press release dated June 01, 2009, titled "Matrix and Aspen complete divestment of Joint Ventures" A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_PR_01062009.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated May 22, 2009, titled "Matrix assigns its right and obligation to purchase 1% equity shares of Astrix Laboratories Limited to Mylan Luxembourg 2 S.a.r.l." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_PR_23052009.ZIP target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated April 20, 2009, titled "Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_Pr_21042009.ZIP target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated March 30, 2009, titled "Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_PR_31032009.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated March 12, 2009, titled "Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat - stable Version of HIV Protease Inhibitor". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_PR_13032009.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the exchange regarding a press release dated February 25, 2009, titled "Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/MatrixLabs_PR_26022009.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated January 14, 2009, titled "Matrix Assigns Part of its Astrix Purchase Rights to Parent Company". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_Pr_15012009.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated October 09, 2008, titled "Matrix And Aspen Agree To Divest Joint Ventures". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_PR_10102008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated June 30, 2008, titled "Jagdish Dore' inducted into the Board as Managing Director of Matrix Laboratories; Rajiv Malik Relocating to U.S. in current Assignment as Head of Global Technical Operations for Mylan". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrixlab_PR_01072008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated June 30, 2008, titled "Matrix announces its Annual Results for year ended 31st March, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrixlab_PRR_01072008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2008, titled "Matrix to Pursue Strategic Alternatives including Potential Divestiture of Docpharma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Martrix_PR_28022008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange that: "Mr. Rajiv Malik, the incumbent Managing Director and Chief Executive Officer of Matrix Laboratories Limited will be relocated to U.S in connection with his employment by the parent company, Mylan Inc. He will be succeeded by Mr. Jagadish Dore. The effective dates for relocation/ date of joining will be finalised subsequently". Further the Company has also submitted to the exchange a copy of press release in this regard dated February 27, 2008, titled "Matrix Laboratories Announces Appointment of Jagdish Dore' as CEO". A copy of the p

Matrix Laboratories Limited has informed the Exchange regarding a press release dated January 24, 2008, titled "Acquisition of Residual Holding in MChem Group of Companies, China". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_PR_25012008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated December 04, 2007 titled "Matrix announces tentative FDA Approval under PEPFAR for Tenofovir Disoproxil Fumarate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/MATRIX_PR_05122007.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated August 24, 2007 titled "Agreement to acquire residual holding in MChem Group of Companies, China". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_PR_240807.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding the press release, titled "Matrix Records Net Sales of Rs.4,470 Million And Net Profit of Rs.269 Million For Q1 FY 08". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_PR_26072007.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated May 23, 2007, titled "Matrix Records Net Sales of Rs.16,480 Million And Net Profit of Rs.763 Million For FY 07". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/MatrixLab_PR240507.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated May 09, 2007, titled "Matrix signs agreement with Clinton Foundation for ARV Drugs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_PR_090507.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release, dated January 31, 2007, titled "Matrix records net sales of Rs. 3,953 million in Q3FY07." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_press_010207.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2007, titled "Mylan Laboratories Completes Matrix Laboratories Transaction". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_Press_090107.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release dated October 31,2006, titled �Matrix records net sales of Rs.3732 million and net profit of Rs.159 million for Q2FY07�. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_PR_31102006.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange regarding a press release, dated, September 22, 2006, titled "Matrix Laboratories Ltd. signs Licensing Agreement with Gilead". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/matrix_nse_220906.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange that the key shareholders of the Company viz., Mr. N. Prasad, India Newbridge Investments Limited, Maxwell (Mauritius) Pte Limited, India Newbridge Coinvestment Limited and India Newbridge Partners FDI Limited and others have entered into agreements with Mylan Laboratories Inc., USA, for sale of their shareholding in Matrix aggregating to 51.54% of the Company's paid-up share capital. In this regard, the Board of Directors of the Company at their meeting held on August 28, 2006 have approved execution of the following agreements with Mylan

Matrix Laboratories Limited has informed the Exchange regarding a press release, dated, July 27, 2006, titled "Matrix records net sales of Rs. 4422 million and net profit of Rs.338 million for Q1FY07". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Matrix Laboratories Limited has informed the Exchange regarding a press release, dated, June 10, 2006, titled "Matrix records net sales of Rs. 11586 million and net profit of Rs.1992 million for FY -06" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Matrix Laboratories Limited has informed the Exchange regarding a press release dated January 30, 2006 titled "Matrix posts consolidated net profit of Rs. 100 Cr for Q3". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Matrix Laboratories Limited has informed the Exchange that the BODs have approved the following: a) for acquiring controlling stake in Concord Biotech Subject to approval of members. b) reconstitution of Share Allotment Committee. A copy of Press Release issue by the Company regarding the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding the press release issued by the company dated October 27, 2005, titled, " Matrix posts, on consolidated basis, record sales of Rs.291.58 crore and net profit of Rs.43.69 crore for Q2.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a press release dated October 05, 2005, titled 'Matrix Laboratories completes the acquisition of Docpharma by obtaining 95.51% stake in the public takeover bid;Squeeze-out bid for all remaining shares not yet tendered'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated September 26, 2005 titled "Matrix enters Definitive Agreement for acquiring controlling stake in Mchem Group, China". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated September 23, 2005 titled "Matrix and Aspen, South Africa, finalize Strategic business relationship".The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated September 20,2005 titled "Matrix acquires 43% stake in Explora, Switzerland- Strategic initiative to gain access to technology platforms and product portfolios such as anti-cancer and corticosteroids". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated July 28, 2005, titled "Matrix reports Rs.154 crore sales and Rs.25 crore PAT for Q1 FY 05-06; New corporate R&D Center at Bollaram inaugurated; US DMFs increased to 50, number of product innovation patens increased to 74; Acquisition of 22 per cent controlling stake in Docpharma, Belgium, completed, draft prospects for the open offer filed with BFIC; FDF facility to initiate ANDA batches in August; Medikon Galenicals, the JV company, commenced Dossier filing in Europe". The details of the press release shall

Matrix Laboratories Limited has informed the Exchange that the BOD's through Circular Resolution have decided to Call-Off Merger plans with Strides Arcolab Limited as both the Companies were unable to reach an agreement on valuation. The details of the press release titled "Matrix and Strides Call-Off Merger Plans", issued by the Company, shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated July 22, 2005 titled "Matrix secured WHO, Geneva, GMP certification for two facilities". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated July 08, 2005 titled "Matrix Laboratories completes share purchase of controlling stake in Docpharma". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange regarding a Press Release dated July 11, 2005, titled "Matrix announces changes in Executive Management structure, Mr. Rajiv Malik to be the new CEO". These changes, wherever necessary, are subject to the approval of the Board. The next Board Meeting is scheduled to be held on July 28, 2005. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the Company has issued a Press Release dated June 21, 2005 titled "Mr. Sanjeev Sethi joins as Sr. Vice President (Pharmaceuticals & Technical Services)". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the Company has issued a press release titled 'Matrix to pay 60% dividend, net at Rs.130 cr for FY -05'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the company has issued a press release dated April 19,2005 titled "US FDA approval for Kazipally facility". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held on April 08, 2005 considered and approved to form two Joint Ventures with Aspen Pharmacare Holdings Limited, South Africa. In this connection the Company has issued a press release titled "Matrix and Aspen, South Africa, to form two JVs". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the company has issued a press release dated April 07,2005 titled "Dr. Gopalan joins as Chief Scientific Officer (CSO)".The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the company has issued a press release dated March 23,2005 titled "Matrix to acquire major stake in MCHEM Pharma Group, China.The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the Company has issued a press release dated March 06, 2005 regarding the fire accident that took place in a production block of one of the manufacturing facilities of the company at Kazipally, near Hyderabad, on March 05, 2005. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the company has issued a press release dated February 07, 2005 titled 'Matrix in strategic alliance with MCHEM of China.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements

Matrix Laboratories Limited has informed the Exchange that the company has issued a press release dated January 27, 2005 titled 'Dr. Haseltine appointed as Chairman of Matrix Scientific Advisory Board (MSAB).' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that that the company has issued a press release dated January 22, 2005 titled 'Matrix labs' Gross sales at Rs.175 cr and Net profit at Rs.25.55 cr for Q3.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the company has issued a press release dated January 19, 2005 titled 'Matrix Labs purchases finished dosage facility.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has submitted to the Exchange additional information (press release) on purchase of Finished Dosage Facility. The details of the press release titled 'Matrix Labs purchases finished dosage facility' shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).